Monograph Wealth Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,126	Closed	-$574K	–	126
2025 Q1	$574K	Sell	2,126 -12	-0.6%	-$3.08K	0.08%	67
2024 Q4	$503K	Buy	2,138 +12	+0.6%	+$3.16K	0.07%	69
2024 Q3	$585K	Hold	2,126	–	–	0.08%	71
2024 Q2	$517K	Hold	2,126	–	–	0.08%	66
2024 Q1	$318K	Sell	2,126 -12	-0.6%	-$2K	0.05%	124
2023 Q4	$409K	Buy	2,138 +12	+0.6%	+$2.04K	0.07%	68
2023 Q3	$377K	Hold	2,126	–	–	0.07%	82
2023 Q2	$404K	Hold	2,126	–	–	0.09%	57
2023 Q1	$426K	Sell	2,126 -16	-0.7%	-$3.36K	0.1%	53
2022 Q4	$509K	Buy	2,142 +16	+0.8%	+$3.41K	0.13%	53
2022 Q3	$426K	Hold	2,126	–	–	0.14%	45
2022 Q2	$310K	Sell	2,126 -8	-0.4%	-$1.14K	0.09%	58
2022 Q1	$348K	Hold	2,134	–	–	0.09%	63
2021 Q4	$362K	Buy	+2,134	New	+$397K	0.09%	61